Antifibrinolytic drugs for acute traumatic injury

Antifibrinolytic drugs for acute traumatic injury

Bibliographic Details
Main Authors:	Ian Roberts, Haleema Shakur, Katharine Ker, Tim Coats
Format:	Article
Language:	English
Published:	Associação Paulista de Medicina
Series:	São Paulo Medical Journal
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802011000500014&lng=en&tlng=en

Similar Items

Antifibrinolytic agents in traumatic haemorrhage.
by: Tim Coats, et al.
Published: (2005-03-01)

Antifibrinolytic Agents in Traumatic Haemorrhage
Published: (2005-01-01)

Response to: The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury - authors' reply
by: Shakur Haleema, et al.
Published: (2009-12-01)

The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial
by: Allen Elizabeth, et al.
Published: (2010-04-01)

Use of the Oxford Handicap Scale at hospital discharge to predict Glasgow Outcome Scale at 6 months in patients with traumatic brain injury
by: Shakur Haleema, et al.
Published: (2008-11-01)

CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury, a nested randomised, placebo-controlled trial.
by: P Perel, et al.
Published: (2012-03-01)

A nested mechanistic sub-study into the effect of tranexamic acid versus placebo on intracranial haemorrhage and cerebral ischaemia in isolated traumatic brain injury: study protocol for a randomised controlled trial (CRASH-3 Trial Intracranial Bleeding Mechanistic Sub-Study [CRASH-3 IBMS])
by: Abda Mahmood, et al.
Published: (2017-07-01)

The effectiveness and safety of antifibrinolytics in patients with acute intracranial haemorrhage: statistical analysis plan for an individual patient data meta-analysis [version 1; referees: 2 approved]
by: Katharine Ker, et al.
Published: (2017-12-01)

The effectiveness and safety of antifibrinolytics in patients with acute intracranial haemorrhage: statistical analysis plan for an individual patient data meta-analysis [version 2; referees: 2 approved]
by: Katharine Ker, et al.
Published: (2018-02-01)

Antifibrinolytics in cardiac surgery
by: Achal Dhir
Published: (2013-01-01)

Antifibrinolytics in liver surgery
by: Jalpa Makwana, et al.
Published: (2010-01-01)

A nested randomised trial of the effect of tranexamic acid on intracranial haemorrhage and infarction in traumatic brain injury (CRASH-3 trial intracranial bleeding mechanistic study): Statistical analysis plan [version 3; peer review: 2 approved, 2 approved with reservations]
by: Abda Mahmood, et al.
Published: (2019-11-01)

A nested randomised trial of the effect of tranexamic acid on intracranial haemorrhage and infarction in traumatic brain injury (CRASH-3 trial intracranial bleeding mechanistic study): Statistical analysis plan [version 2; peer review: 2 approved, 1 approved with reservations]
by: Abda Mahmood, et al.
Published: (2019-01-01)

Using antifibrinolytics to tackle neuroinflammation
by: Stanimir Atsev, et al.
Published: (2020-01-01)

AntifibrinolyticAgents: Aprotinin, and Desmopressin
by: Pramila Bajaj
Published: (2009-01-01)

Cost-effectiveness analysis of tranexamic acid for the treatment of traumatic brain injury, based on the results of the CRASH-3 randomised trial: a decision modelling approach
by: Ian Roberts, et al.
Published: (2020-09-01)

Outcome measures in clinical trials of treatments for acute severe haemorrhage
by: Amy Brenner, et al.
Published: (2018-10-01)

Avoidable mortality from giving tranexamic acid to bleeding trauma patients: an estimation based on WHO mortality data, a systematic literature review and data from the CRASH-2 trial
by: Ker Katharine, et al.
Published: (2012-03-01)

Antifibrinolytics and cardiac surgery: The past, the present, and the future
by: Naresh K Aggarwal, et al.
Published: (2020-01-01)

CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial
by: Dewan Yashbir, et al.
Published: (2012-06-01)

The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery.
by: Chih-Yuan Lin, et al.
Published: (2015-01-01)

Secretion and Antifibrinolytic Function of TAFI from Human Platelets
by: Schadinger, Steven Leonard
Published: (2009)

Current Status of Blood Transfusion and Antifibrinolytic Therapy in Orthopedic Surgeries
by: Nicoleta eStoicea, et al.
Published: (2015-02-01)

Significant Hyperfibrinolysis in a Patient With Intracardiac Thrombosis: To Give Antifibrinolytics or Not?
by: Eric R. Simon, MD, et al.
Published: (2019-03-01)

Revisiting the antifibrinolytic effect of carboxypeptidase N: novel structure and regulation
by: Swanson, Pascale Libront
Published: (2010)

Risk factors for blood transfusion in traumatic and postpartum hemorrhage patients: Analysis of the CRASH-2 and WOMAN trials.
by: David A Kolin, et al.
Published: (2020-01-01)

Efficacy and safety of antifibrinolytic agents in spinal surgery: a network meta-analysis
by: Lei Yuan, et al.
Published: (2019-03-01)

Tranexamic Acid in Civilian Trauma Care in the California Prehospital Antifibrinolytic Therapy Study
by: Michael M. Neeki, et al.
Published: (2018-10-01)

Efficacy and safety of antifibrinolytics in oncological surgery: a systematic review and meta-analysis
by: Aline Menezes Sampaio, et al.
Published: (2019-09-01)

Efficacy and safety of using antifibrinolytic agents in spine surgery: a meta-analysis.
by: Chaoqun Yuan, et al.
Published: (2013-01-01)

Quinapril decreases antifibrinolytic and prooxidative potential of propofol in arterial thrombosis in hypertensive rats
by: Marzena Wojewodzka-Zelezniakowicz, et al.
Published: (2016-05-01)

Tranexamic acid for significant traumatic brain injury (The CRASH-3 trial): Statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial [version 1; referees: 2 approved]
by: Ian Roberts, et al.
Published: (2018-07-01)

Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery? A meta-analysis of randomized head-to-head trials
by: Stokes Barrie J, et al.
Published: (2005-07-01)

Effect of antifibrinolytic drugs on transfusion requirement and blood loss during orthotopic liver transplantation: Results from a single center
by: Devi A, et al.
Published: (2008-01-01)

Acute Traumatic Injury of the Larynx
by: K. O. Kragha
Published: (2015-01-01)

Maternal malaria induces a procoagulant and antifibrinolytic state that is embryotoxic but responsive to anticoagulant therapy.
by: John W Avery, et al.
Published: (2012-01-01)

Tranexamic acid for significant traumatic brain injury (The CRASH-3 trial): Statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial [version 2; referees: 3 approved, 1 approved with reservations]
by: Ian Roberts, et al.
Published: (2018-09-01)

Drug-based neuroprotection in acute phase of traumatic brain injury of moderate severity
by: A. E. Talypov, et al.
Published: (2015-12-01)

Antifibrinolytic role of a bee venom serine protease inhibitor that acts as a plasmin inhibitor.
by: Young Moo Choo, et al.
Published: (2012-01-01)

Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT
by: Ian Roberts, et al.
Published: (2021-04-01)

Cannot write session to /tmp/vufind_sessions/sess_t6ovpbe1alh8bguujfaripcjnf